Stockscreener 앱 받기
1.48
2.07%
0.03
시간 외 거래:
1.46
-0.02
-1.35%
전일 마감가:
$1.45
열려 있는:
$1.47
하루 거래량:
198.56K
Relative Volume:
0.70
시가총액:
$76.89M
수익:
-
순이익/손실:
$-51.47M
주가수익비율:
-1.48
EPS:
-1
순현금흐름:
$-47.50M
1주 성능:
+5.71%
1개월 성능:
+12.12%
6개월 성능:
+2.78%
1년 성능:
+1.37%
1일 변동 폭
$1.455
$1.52
1주일 범위
$1.38
$1.52
52주 변동 폭
$0.81
$1.82
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
명칭
Pmv Pharmaceuticals Inc
전화
(609) 642-6670
주소
400 ALEXANDER PARK DRIVE, PRINCETON
PMVP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.48 | 78.97M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-05-13 | 개시 | Craig Hallum | Buy |
| 2024-04-12 | 개시 | Jefferies | Buy |
| 2023-12-27 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-22 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-08-19 | 개시 | Oppenheimer | Perform |
| 2021-08-02 | 개시 | Guggenheim | Buy |
| 2021-07-29 | 개시 | H.C. Wainwright | Buy |
| 2020-10-20 | 개시 | BofA Securities | Buy |
| 2020-10-20 | 개시 | Cowen | Outperform |
| 2020-10-20 | 개시 | Evercore ISI | Outperform |
| 2020-10-20 | 개시 | Goldman | Neutral |
모두보기
Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionFree Short Term Setup With Predictive Chart - Newser
How high can PMV Pharmaceuticals Inc. stock goSwing Trade Watchlist with Entry Zones - Newser
Is PMV Pharmaceuticals Inc. a candidate for recovery playTechnical Reversal Setup with Risk Limits - Newser
PMV Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks
Can you recover from losses in PMV Pharmaceuticals Inc.Momentum-Based Prediction for Quick Returns - Newser
PMV Pharmaceuticals Inc. recovery potential after sell offAI-Based Signal Detection for Active Traders - Newser
Earnings visualization tools for PMV Pharmaceuticals Inc.Free Capital Preserving Trade Plan Templates - Newser
Will PMV Pharmaceuticals Inc. rebound enough to break evenEntry Optimization Tool with Screener Logic - Newser
Should you hold or exit PMV Pharmaceuticals Inc. nowSummary of Consistent Growth Stock Picks - Newser
Top chart patterns to watch in PMV Pharmaceuticals Inc.Free Alpha Focused Technical Trade Signals - Newser
Technical signs of recovery in PMV Pharmaceuticals Inc.Swing Entry Insight With Forecast Accuracy - Newser
Is PMV Pharmaceuticals Inc. reversing from oversold territoryDaily Trade Setup Forecast with Confidence - Newser
Is PMV Pharmaceuticals Inc. forming a reversal patternFree Growth Based Investment Plan Guidance - Newser
What MACD and RSI say about PMV Pharmaceuticals Inc.Free Alpha Focused Technical Trade Signals - Newser
Should you wait for a breakout in PMV Pharmaceuticals Inc.High Conviction Stock Long-Term Summary - Newser
Published on: 2025-08-08 18:31:10 - Newser
Analyzing recovery setups for PMV Pharmaceuticals Inc. investorsAsset Growth Pattern and Return Summary - Newser
How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsWeekly Stock Market Strategy Summary - Newser
PMV Pharmaceuticals (PMVP) Q2 Loss Jumps - AOL.com
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire
PMV Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
PMV Pharmaceuticals Reports Q2 GAAP EPS of -$0.41, Misses by $0.02 - AInvest
PMV Pharmaceuticals Pours Cash Into R&D, Analysts Stay Bullish - Finimize
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights | PMVP Stock News - GuruFocus
Evaluating PMV Pharmaceuticals' Path to Value Creation Amid Q2 2025 Losses and PYNNACLE Trial Progress - AInvest
PMV Pharmaceuticals, Inc. to Host Investor Webinar on Phase 2 PYNNACLE Clinical Trial Interim Analysis on September 10, 2025 - Quiver Quantitative
PMV Pharma to Reveal Phase 2 PYNNACLE Trial Results: 65 Cancer Patients, $148M Cash Through 2026 - Stock Titan
Pmv Pharmaceuticals Inc reports Q2 net loss of $21.2 million - MarketScreener
PMV Pharmaceuticals (PMVP) to Release Quarterly Earnings on Thursday - Defense World
Is a relief rally coming for PMV Pharmaceuticals Inc. holdersEarly Entry Planner for Swing Candidates - Newser
PMV Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Trade Setups With AI Powered Filters - Newser
Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsFree Trend Following Strategy With Stop Loss - Newser
Ichimoku Cloud Indicates Uncertainty Around PMV Pharmaceuticals Inc.Watchlist for Low Risk High Return Stocks Updated - beatles.ru
What analysts say about PMV Pharmaceuticals Inc. stock outlookFree Step-by-Step Stock Investment Guide - Newser
What to do if you’re stuck in PMV Pharmaceuticals Inc.AI-Based Signal Detection for Active Traders - Newser
Should I hold or sell PMV Pharmaceuticals Inc. stock in 2025Dynamic profit opportunities - Jammu Links News
Is PMV Pharmaceuticals Inc. forming a bottoming basePrice Action Summary and Entry Strategy Guide - Newser
What are the technical indicators suggesting about PMV Pharmaceuticals Inc.Get timely alerts on top market movers - Jammu Links News
How does PMV Pharmaceuticals Inc. compare to its industry peersUnlock exclusive trading strategies for gains - Jammu Links News
Pmv Pharmaceuticals Inc (PMVP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):